International Breast Cancer Study Group

28.9k citations
494 papers ·

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 10%
    • HER2/EGFR in Cancer Research
    • Cancer Risks and Factors
    • Cancer Treatment and Pharmacology

Papers in

    • Breast Cancer Treatment Studies 163
    • Cancer Treatment and Pharmacology 52
    • HER2/EGFR in Cancer Research 46
    • Cancer Risks and Factors 28
    • Cancer Immunotherapy and Biomarkers 19
    • Cancer survivorship and care 18

International Breast Cancer Study Group

399 papers receiving 21.8k citations

Peers

International Breast Cancer Study Group
Comparison fields: 5 of 190
  • Cancer Research 11.0k
  • Oncology 11.0k
  • Genetics 4.2k
  • Pathology and Forensic Medicine 2.3k
  • Hepatology 1.0k
Replace Clinique de Genolier with:
Clinique de Genolier Switzerland
Biogen (Switzerland) Switzerland
International Drug Development Institute (Belgium) Belgium
German Breast group Germany
Gefluc Languedoc Roussillon France
Instituut Verbeeten Netherlands
Children's Oncology Group Switzerland
European School of Oncology Italy
Bristol-Myers Squibb (Belgium) Belgium
Institut Sainte Catherine France
International Breast Cancer Study Group relative to Clinique de Genolier Switzerland Clinique de Genolier's profile →
Citations per field
00.5×7.3×
Clinique de Genolier · 1×
Citations per year

Countries citing scholars working at International Breast Cancer Study Group

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at International Breast Cancer Study Group. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at International Breast Cancer Study Group with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites International Breast Cancer Study Group more than expected).

Fields of papers published by authors at International Breast Cancer Study Group

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with International Breast Cancer Study Group at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with International Breast Cancer Study Group at the time of their publication.

About International Breast Cancer Study Group

In recent decades, authors affiliated with International Breast Cancer Study Group have published 494 papers, which have received a total of 28.9k indexed citations . Scholars at this organization have produced 175 papers in Cancer Research, 183 papers in Oncology, 102 papers in Pulmonary and Respiratory Medicine, 76 papers in Genetics and 19 papers in Hepatology on the topics of Breast Cancer Treatment Studies (163 papers), Estrogen and related hormone effects (66 papers), Advanced Breast Cancer Therapies (56 papers), Cancer Treatment and Pharmacology (52 papers), HER2/EGFR in Cancer Research (46 papers), Cancer Risks and Factors (28 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Cancer survivorship and care (18 papers). Their work is cited by papers focused on Cancer Research (11.0k citations), Oncology (11.0k citations), Genetics (4.2k citations), Pathology and Forensic Medicine (2.3k citations) and Hepatology (1.0k citations). Authors at International Breast Cancer Study Group collaborate with scholars in Switzerland, United States and Italy and have published in prestigious journals including Annals of Oncology, Journal of Clinical Oncology, Cancer Research, European Journal of Cancer and Breast Cancer Research and Treatment. Some of International Breast Cancer Study Group's most productive authors include Aron Goldhirsch, Richard D. Gelber, Alan S. Coates, Beat Thürlimann, Hans-Jörg Senn, W. C. Wood, Monica Castiglione‐Gertsch, John H. Glick, Karen N. Price and Marco Colleoni.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact